HOMCOS:

#WARNING:no index is registered index "YP_009724391.1" in "https://rest.uniprot.org/uniprotkb/" url "https://rest.uniprot.org/uniprotkb/YP_009724391.1.txt".
Please visit the UniProt website(https://www.uniprot.org), and get a proper ID/AC for your query protein.

		Contact Molecules for Homologous Proteins
[Summary Bars]	[Full Bars]	Site Table[30 %]	[Back to Search Page]	[Back to HOMCOS]
[Sites by Variants]	[SupCon3D]	[help]	seq_id(%): [0] [30] [40] [50] [60] [70] [80] [90] [95] [100]	[show] [download] [help]

PID

QueryLength

Homolgous Sequence in PDB

UniProt Query

TITLE

29044

275

YP_009724391.1()

QUERYSEQ

MDLFMRIFTIGTVTLKQGEIKDATPSDFVRATATIPIQASLPFGWLIVGVALLAVFQSASKIITLKKRWQLALSKGVHFVCNLLLLFVTVYSHLLLVAAGLEAPFLYLYALVYFLQSINFVRIIMRLWLCWKCRSKNPLLYDANYFLCWH
TNCYDYCIPYNSVTSSIVITSGDGTTSPISEHDYQIGGYTEKWESGVKDCVVLHSYFTSDYYQLYSTQLSTDTGVEHVTFFIYNKIVDEPEEHVQIHTIDGSSGVVNPVMEPIYDEPTTTTSVPL

[BLAST file for PDB] (plain) (bar) (multiple alignment) [BLAST for UniProt: (plain) (bar) (multiple alignment) (PSSM file) ]

  [n]:site number of query sequence.  [a]:amino acid of query sequence.  [s]:predicted secondary structure.
  [e]:predicted exposed/buried.  [acc]:predicted relative accesssibility(%).  [pdb]:PDB code of homologous structure.
  [contact_mols]:predicted binding molecules  [observed aa]:Observed amino acids among homologous sequences.  [feature table]:UniProt Feature Table
  [variant]:UniProt Human Variant.

n	a	s	e	acc	pdb	contact_mols	observed aa	feature table	variant
1	M	-	-	-	-		M	DISORDER predicted by DISOPRED
2	D	-	-	-	-		D	DISORDER predicted by DISOPRED
3	L	-	-	-	-		L	DISORDER predicted by DISOPRED
4	F	-	-	-	-		F	DISORDER predicted by DISOPRED
5	M	-	-	-	-		M	DISORDER predicted by DISOPRED
6	R	-	-	-	-		RS	DISORDER predicted by DISOPRED
7	I	-	-	-	-		IF
8	F	-	-	-	-		F	DISORDER predicted by DISOPRED
9	T	-	-	-	-		T
10	I	-	-	-	-		LI	DISORDER predicted by DISOPRED
11	G	-	-	-	-		G	DISORDER predicted by DISOPRED
12	T	-	-	-	-		ATS	DISORDER predicted by DISOPRED
13	V	-	-	-	-		IV	DISORDER predicted by DISOPRED
14	T	-	-	-	-		T	DISORDER predicted by DISOPRED
15	L	-	-	-	-		RLA	DISORDER predicted by DISOPRED
16	K	-	-	-	-		QKN
17	Q	-	-	-	-		PQ
18	G	-	-	-	-		AGV
19	E	-	-	-	-		KE
20	I	-	-	-	-		IV
21	K	-	-	-	-		EKD
22	D	-	-	-	-		ND
23	A	-	-	-	-		A
24	T	-	-	-	-		ST
25	P	-	-	-	-		P
26	S	-	-	-	-		AS
27	D	-	-	-	-		SD
28	F	-	-	-	-		TF
29	V	-	-	-	-		V
30	R	-	-	-	-		HR
31	A	-	-	-	-		A
32	T	-	-	-	-		T
33	A	-	-	-	-		A
34	T	-	-	-	-		T
35	I	-	-	-	-		I
36	P	-	-	-	-		P
37	I	-	-	-	-		LI
38	Q	-	-	-	-		Q
39	A	-	-	-	-		A
40	S		e	131.2	6xdc_B		ST
41	L		e	38.8	6xdc_B		LF
42	P		e	48.1	6xdc_B		P
43	F	S	e	76.6	6xdc_B	homo	F
44	G	H	e	56.0	6xdc_B		G
45	W	H	e	62.2	6xdc_B		W
46	L	H	e	26.4	6xdc_B	homo	L
47	I	H	e	67.8	6xdc_B	homo	IV
48	V	H	e	42.7	6xdc_B	homo	VI
49	G	H	b	4.8	6xdc_B		G
50	V	H	e	49.3	6xdc_B	homo	V
51	A	H	e	48.2	6xdc_B	homo	A
52	L	H	e	47.2	6xdc_B		LF
53	L	H	b	15.7	6xdc_B	homo	L
54	A	H	e	45.5	6xdc_B	homo	A
55	V	H	e	62.7	6xdc_B	homo	V
56	F	H	e	34.0	6xdc_B		F
57	Q	H	e	44.9	6xdc_B	homo	Q
58	S	H	e	64.1	6xdc_B	homo	S
59	A	H	e	37.5	6xdc_B	homo	A
60	S	H	b	10.9	6xdc_B		ST
61	K	T	e	76.4	6xdc_B	compound PEE homo	K
62	I	T	e	81.3	6xdc_B	hetero APOA1_HUMAN compound PEE homo	IV
63	I		e	28.1	6xdc_B	hetero APOA1_HUMAN compound PEE	I
64	T		e	56.5	6xdc_B	hetero APOA1_HUMAN SAP_HUMAN compound PEE homo	AT
65	L		e	51.1	6xdc_B	homo	L
66	K		e	79.2	6xdc_B	homo	HKN
67	K	S	e	61.8	6xdc_B	hetero APOA1_HUMAN	KR
68	R	H	e	45.8	6xdc_B		R
69	W	H	e	68.5	6xdc_B	hetero APOA1_HUMAN	W
70	Q	H	b	16.3	6xdc_B	hetero APOA1_HUMAN	Q
71	L	H	b	5.1	6xdc_B		L
72	A	H	e	47.3	6xdc_B	compound PEE	A
73	L	H	e	47.2	6xdc_B		L
74	S	H	b	0.8	6xdc_B	compound PEE	YS
75	K	H	e	27.4	6xdc_B	compound PEE	K
76	G	H	e	45.2	6xdc_B	compound PEE	G
77	V	H	b	15.3	6xdc_B		VFI
78	H	H	e	43.5	6xdc_B	compound PEE	QH
79	F	H	e	58.9	6xdc_B	compound PEE	FL
80	V	H	e	33.3	6xdc_B		VI
81	C	H	b	8.0	6xdc_B		C
82	N	H	e	24.8	6xdc_B	homo	N
83	L	H	e	52.2	6xdc_B		LM
84	L	H	b	19.1	6xdc_B		L
85	L	H	e	43.3	6xdc_B	homo	L
86	L	H	e	38.2	6xdc_B		L
87	F	H	e	39.2	6xdc_B		F
88	V	H	b	10.0	6xdc_B	homo	V
89	T	H	b	10.4	6xdc_B	homo	T
90	V	H	e	41.3	6xdc_B		IV
91	Y	H	b	13.9	6xdc_B		Y
92	S	H	b	18.0	6xdc_B	homo	S
93	H	H	e	22.5	6xdc_B		H
94	L	H	e	44.4	6xdc_B		L
95	L	H	b	12.9	6xdc_B		L
96	L	H	e	30.9	6xdc_B	homo	L
97	V	H	e	55.3	6xdc_B		VL
98	A	H	e	69.6	6xdc_B		A
99	A	H	e	76.8	6xdc_B		A
100	G		e	72.6	6xdc_B		GC
101	L		e	24.2	6xdc_B		ML
102	E		e	57.8	6xdc_B		E
103	A	H	e	50.9	6xdc_B		A
104	P	H	e	42.6	6xdc_B		QP
105	F	H	e	42.1	6xdc_B	homo	F
106	L	H	e	52.2	6xdc_B		L
107	Y	H	e	68.3	6xdc_B	hetero	Y
108	L	H	e	50.0	6xdc_B	homo	LI
109	Y	H	b	11.7	6xdc_B	homo	Y
110	A	H	e	47.3	6xdc_B		A
111	L	H	e	53.4	6xdc_B		L
112	V	H	e	34.0	6xdc_B	homo	IV
113	Y	H	e	34.8	6xdc_B		Y
114	F	H	e	58.9	6xdc_B	hetero SAP_HUMAN	FI
115	L	H	e	56.7	6xdc_B	homo	L
116	Q	H	e	21.4	6xdc_B	homo	Q
117	S	H	e	42.2	6xdc_B		ISC
118	I	H	e	49.7	6xdc_B	hetero SAP_HUMAN compound PEE homo	IV
119	N	H	e	24.8	6xdc_B	homo	NS
120	F	H	e	62.7	6xdc_B		FA
121	V	H	e	48.0	6xdc_B	hetero APOA1_HUMAN SAP_HUMAN compound PEE	CV
122	R	H	e	41.1	6xdc_B	hetero SAP_HUMAN compound PEE homo	R
123	I	H	e	32.7	6xdc_B	compound PEE	IF
124	I	H	e	45.0	6xdc_B		I
125	M	H	e	22.2	6xdc_B	hetero APOA1_HUMAN	M
126	R	H	b	11.9	6xdc_B	compound PEE	R
127	L	H	e	51.7	6xdc_B	compound PEE	CL
128	W	H	e	47.4	6xdc_B	hetero APOA1_HUMAN	W
129	L	H	b	0.6	6xdc_B		L
130	C	H	b	7.3	6xdc_B		C
131	W	H	e	73.7	6xdc_B		W
132	K	H	e	22.2	6xdc_B	hetero APOA1_HUMAN	K
133	C	T	b	4.7	6xdc_B		C
134	R	T	e	60.1	6xdc_B		RK
135	S	S	b	12.5	6xdc_B		S
136	K	S	e	67.9	6xdc_B		K
137	N	H	b	1.8	6xdc_B		N
138	P	H	b	1.6	6xdc_B		P
139	L	H	e	37.1	6xdc_B		L
140	L	H	b	12.9	6xdc_B	compound PEE	L
141	Y	S	e	21.7	6xdc_B		Y
142	D		e	63.6	6xdc_B		D
143	A		b	11.6	6xdc_B		A
144	N	S	e	57.0	6xdc_B	compound PEE homo	N
145	Y	E	e	23.5	6xdc_B	homo	Y
146	F	E	b	0.0	6xdc_B		F
147	L	E	b	0.0	6xdc_B		VL
148	C	E	b	6.7	6xdc_B		C
149	W		b	5.2	6xdc_B		W
150	H	B	e	49.7	6xdc_B		H
151	T		b	0.0	6xdc_B		T
152	N	S	e	86.1	6xdc_B		NH
153	C	S	e	58.0	6xdc_B		CN
154	Y		e	28.7	6xdc_B		YF
155	D	B	e	21.6	6xdc_B		D
156	Y		b	0.4	6xdc_B		Y
157	C		b	0.7	6xdc_B		C
158	I	E	b	1.2	6xdc_B		I
159	P	E	b	2.3	6xdc_B		P
160	Y	E	b	16.5	6xdc_B	homo	Y
161	N		e	69.7	6xdc_B	homo	N
162	S	S	e	39.8	6xdc_B	homo	S
163	V		e	31.3	6xdc_B		VI
164	T		e	40.9	6xdc_B	homo	T
165	S	S	e	47.7	6xdc_B	homo	DS
166	S	E	e	49.2	6xdc_B	homo	TS
167	I	E	b	0.0	6xdc_B		IV
168	V	E	e	44.0	6xdc_B	homo	V
169	I	E	b	0.0	6xdc_B		IVL
170	T	E	b	16.2	6xdc_B	homo	T
171	S	E	b	10.2	6xdc_B		SE
172	G	E	b	16.7	6xdc_B		G
173	D		e	53.7	6xdc_B	homo	D
174	G		e	91.7	6xdc_B		G
175	T	-	-	-	-		TI
176	T	-	-	-	-		TSN
177	S	-	-	-	-		QST
178	P	-	-	-	-		P
179	I	-	-	-	-		KI
180	S	-	-	-	-		LS
181	E		e	82.4	6xdc_B		KE
182	H		e	33.0	6xdc_B		EH
183	D	E	b	18.5	6xdc_B		D
184	Y	E	b	3.9	6xdc_B		Y
185	Q	E	e	39.3	6xdc_B	homo	Q
186	I	E	b	6.4	6xdc_B		I
187	G	T	e	98.8	6xdc_B	homo	G
188	G	T	e	65.5	6xdc_B	homo	G
189	Y	E	e	44.3	6xdc_B	homo	Y
190	T	E	e	40.9	6xdc_B		ST
191	E	E	b	5.5	6xdc_B		E
192	K	E	e	64.6	6xdc_B		DK
193	W		e	41.0	6xdc_B		WR
194	E	S	e	41.7	6xdc_B		HE
195	S	S	e	37.5	6xdc_B		S
196	G		e	21.4	6xdc_B		G
197	V		e	33.3	6xdc_B		V
198	K		e	34.0	6xdc_B		K
199	D	S	e	63.6	6xdc_B		D
200	C	E	e	52.0	6xdc_B		YC
201	V	E	b	0.0	6xdc_B		V
202	V	E	b	17.3	6xdc_B		V
203	L	E	b	0.0	6xdc_B		ILV
204	H	E	b	15.2	6xdc_B		HY
205	S		b	12.5	6xdc_B		GS
206	Y	S	e	23.5	6xdc_B	hetero APOA1_HUMAN SAP_HUMAN compound PEE	Y
207	F	S	e	81.8	6xdc_B	hetero APOA1_HUMAN SAP_HUMAN compound PEE	F
208	T		e	39.0	6xdc_B	hetero SAP_HUMAN	T
209	S	E	e	28.9	6xdc_B	hetero APOA1_HUMAN	ES
210	D	E	e	29.6	6xdc_B		VDI
211	Y	E	e	55.7	6xdc_B		Y
212	Y	E	b	0.0	6xdc_B		Y
213	Q	E	e	42.9	6xdc_B		Q
214	L	E	e	21.9	6xdc_B		L
215	Y	E	e	68.7	6xdc_B	homo	EY
216	S	E	e	58.6	6xdc_B	homo	S
217	T	E	e	39.0	6xdc_B		T
218	Q	E	e	27.0	6xdc_B	homo	Q
219	L		e	50.6	6xdc_B		LI
220	S	H	e	40.6	6xdc_B		ST
221	T	H	e	79.9	6xdc_B		T
222	D	H	e	72.2	6xdc_B	homo	D
223	T	H	e	40.3	6xdc_B	homo	T
224	G		e	66.7	6xdc_B	homo	G
225	V		e	54.0	6xdc_B	homo	AVI
226	E	T	e	69.8	6xdc_B		E
227	H	T	e	58.6	6xdc_B		NH
228	V	E	e	25.3	6xdc_B	homo	AV
229	T	E	e	22.7	6xdc_B		T
230	F	E	e	23.0	6xdc_B	homo	F
231	F	E	b	12.0	6xdc_B		F
232	I	E	e	36.3	6xdc_B	homo	I
233	Y	E	b	0.0	6xdc_B		YF
234	N	E	e	32.1	6xdc_B	homo	NS
235	K	E	e	29.2	6xdc_B		K
236	I		e	40.4	6xdc_B		LI
237	V		e	84.7	6xdc_B		V
238	D		e	109.9	6xdc_B		KD
239	E	-	-	-	-		DE
240	P	-	-	-	-		PALEGKSTVDFINQRCHMWY
241	E	-	-	-	-		VEAGLSDFHIKMNPQRTY
242	E	-	-	-	-		DEP
243	H	-	-	-	-		HN
244	V	-	-	-	-		V
245	Q	-	-	-	-		Q
246	I	-	-	-	-		I
247	H	-	-	-	-		H
248	T	-	-	-	-		T
249	I	-	-	-	-		I
250	D	-	-	-	-		D
251	G	-	-	-	-		G
252	S	-	-	-	-		S
253	S	-	-	-	-		S
254	G	-	-	-	-		G
255	V	-	-	-	-		V
256	V	-	-	-	-		VA
257	N	-	-	-	-		N
258	P	-	-	-	-		P
259	V	-	-	-	-		AV
260	M	-	-	-	-		M
261	E	-	-	-	-		DE
262	P	-	-	-	-		P
263	I	-	-	-	-		I
264	Y	-	-	-	-		Y
265	D	-	-	-	-		D
266	E	-	-	-	-		E
267	P	-	-	-	-		P	DISORDER predicted by DISOPRED
268	T	-	-	-	-		T	DISORDER predicted by DISOPRED
269	T	-	-	-	-		T	DISORDER predicted by DISOPRED
270	T	-	-	-	-		T	DISORDER predicted by DISOPRED
271	T	-	-	-	-		T	DISORDER predicted by DISOPRED
272	S	-	-	-	-		S	DISORDER predicted by DISOPRED
273	V	-	-	-	-		V	DISORDER predicted by DISOPRED
274	P	-	-	-	-		P	DISORDER predicted by DISOPRED
275	L	-	-	-	-		L	DISORDER predicted by DISOPRED

Contact Molecules for Homologous Proteins

Site Table[30 %]